Parkman Healthcare Partners LLC Portfolio Holdings

Parkman Healthcare Partners LLC

  • $799 Million
  • Q3 2025

Parkman Healthcare Partners LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $799 Million distributed in 91 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $42.4M, Alnylam Pharmaceuticals, Inc. with a value of $40M, Insulet Corp with a value of $35.9M, Cvs Health Corp with a value of $28.6M, and Viridian Therapeutics, Inc.\De with a value of $24.8M.

Examining the 13F form we can see an increase of $53.3M in the current position value, from $746M to 799M.

Parkman Healthcare Partners LLC is based out at Stamford, CT

Below you can find more details about Parkman Healthcare Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $799 Million
Healthcare: $751 Million
ETFs: $48 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 91
  • Current Value $799 Million
  • Prior Value $746 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 14 stocks
  • Additional Purchases 39 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 35 stocks
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email